Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-03-11
1994-10-04
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514214, 540477, 540582, 546114, A61K 31435, C07D49504
Patent
active
053526856
ABSTRACT:
The thieno[3.2-b]pyridine derivative of the present invention promote the gastric emptying in male ddy mice and the gastric contraction in dogs sutured with a strain-gauge transducer. It is believed that the derivatives have the action to enhance gastric motor action and gastric emptying. Therefore, the compound of the present invention are effective for the prevention and therapeutical treatment of the symptoms caused by gastric hypanakinesis, such as heartburn, abdominal distension feeling, anorexia, unpleasant feeling on upper abdomen, abdominalgia, nausea, vomiting, etc. caused by the underlying diseases such as acute and chronic gastritis, stomach and duodenum ulcer, gastroneurosis, gastroptosis, etc. The present invention also encompasses a pharmaceutical composition containing as the effective ingredient a compound of the present invention, and a method for producing the same.
REFERENCES:
patent: 4910193 (1990-03-01), Buchheit
patent: 5106851 (1992-04-01), Turconi et al.
Maruyama Akira
Ogawa Shigeru
Tobe Akihiro
Yamazaki Satoshi
Dentz Bernard
Mitsubishi Kasei Corporation
LandOfFree
Thieno[3,2-b]pyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thieno[3,2-b]pyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thieno[3,2-b]pyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581488